Research & Development

Can POLB 001 Revolutionize CRS Treatment in Cancer Immunotherapy?
Research & Development Can POLB 001 Revolutionize CRS Treatment in Cancer Immunotherapy?

In a significant breakthrough, Poolbeg Pharma announced positive pre-clinical study results for their drug POLB 001, presented at the 66th American Society of Hematology (ASH) Annual Meeting. The study focused on the drug's potential to prevent Cytokine Release Syndrome (CRS), a frequently

Study Links Ultra-Processed Foods to Increased Risk of Colorectal Cancer
Research & Development Study Links Ultra-Processed Foods to Increased Risk of Colorectal Cancer

A recent study spearheaded by University of South Florida (USF) Health researchers, in collaboration with TGH Cancer Institute, has unveiled a potential link between ultra-processed foods and an increased risk of colorectal cancer. Researchers highlighted how these foods may contribute to chronic

Oncologists Maintain Care Amidst Platinum Chemotherapy Drug Shortage
Research & Development Oncologists Maintain Care Amidst Platinum Chemotherapy Drug Shortage

In early 2023, the FDA's announcement of a shortage of two critical generic platinum chemotherapy drugs, cisplatin and carboplatin, alarmed the medical community. These drugs have been essential in the treatment of various advanced cancers for over 30 years, particularly lung, head and neck,

Unlocking Cancer Therapy: Overcoming Hypoxia-Induced Resistance
Research & Development Unlocking Cancer Therapy: Overcoming Hypoxia-Induced Resistance

Advancements in cancer therapy have brought significant hope, especially with immune checkpoint blockades (ICBs), providing a groundbreaking treatment strategy for advanced cancers. Despite this, the effectiveness of ICBs has often been thwarted by therapeutic resistance, which renders

USC Awarded $3.4M to Tackle Cognitive Decline in Aging Women
Research & Development USC Awarded $3.4M to Tackle Cognitive Decline in Aging Women

The Keck School of Medicine of USC has embarked on a groundbreaking research initiative aimed at addressing age-related cognitive decline in women. This significant effort is led by Dr. Young-Kwon Hong and has been bolstered by securing a $3.4 million federal grant from the Advanced Research

Can Innovative Tech Improve Long-Term Outcomes in Pediatric AE?
Research & Development Can Innovative Tech Improve Long-Term Outcomes in Pediatric AE?

Autoimmune encephalitis (AE), a condition where the body's immune system turns against the brain, affects approximately one-third of global encephalitis cases and often leads to debilitating symptoms, including seizures, cognitive impairment, and motor dysfunctions. Despite advancements in

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later